← All organizations
Highest phase reached
Phase 3
First clinical trial
May 1, 2002Last known activity
Apr 5, 2023
Timeline
1970s
- Jun 1, 1979
Transgene— Founded
Drugs by trial phase (23 distinct, 21 trials)
Phase 3 (4 own, 0 via acquisition)
Phase 2 (13 own, 0 via acquisition)
Indications
Studied for
- Brain Neoplasms
- Carcinoma
- Carcinoma, Hepatocellular
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Ovarian Epithelial
- Carcinoma, Squamous Cell
- Colorectal Neoplasms
- Digestive System Neoplasms
- Fallopian Tube Neoplasms
- Gastrointestinal Neoplasms
- Glioblastoma
- Hepatitis
- Hepatitis A
- Hepatitis B
- Hepatitis B, Chronic
- Hepatitis C
- Hepatitis C, Chronic
- Lung Neoplasms
- Lymphoma
- Lymphoma, B-Cell
- Neoplasm Metastasis
- Neoplasms
- Ovarian Neoplasms
- Prostatic Neoplasms
- Squamous Cell Carcinoma of Head and Neck
- Vaccinia
Recent trials (21)
- NCT05788926Lead sponsorPhase 1Apr 5, 2023
- NCT04725331Lead sponsorPhase 1/Phase 2Feb 25, 2021
- NCT04194034Lead sponsorPhase 1/Phase 2Dec 31, 2019
- NCT03839524Lead sponsorPhase 1Dec 31, 2019
- NCT04183166Lead sponsorPhase 1Nov 29, 2019
- NCT03724071Lead sponsorPhase 1/Phase 2Oct 16, 2018
- NCT03353675Lead sponsorPhase 2Jan 16, 2018
- NCT03294486CollaboratorPhase 1/Phase 2Oct 12, 2017
- NCT03260023Lead sponsorPhase 1/Phase 2Sep 11, 2017
- NCT03071094Lead sponsorPhase 1/Phase 2Apr 1, 2017
- NCT02977156CollaboratorPhase 1Jan 3, 2017
- NCT02823990CollaboratorPhase 2Dec 1, 2016
- NCT02428400Lead sponsorPhase 1Oct 1, 2015
- NCT01383148Lead sponsorPhase 2/Phase 3Apr 1, 2012
- NCT01394939CollaboratorPhase 1/Phase 2Jan 1, 2012
Details
- Founded
- Illkirch-graffenstaden, FR Jun 1, 1979
- Last known activity
- Apr 5, 2023